DNTH icon

Dianthus Therapeutics
DNTH

Overview Fund Activity

74 hedge funds and large institutions have $769M invested in Dianthus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 30 closing their positions.

Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.08%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
28
Increased
19
Reduced
16
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$41.5M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$32.2M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$12.9M
4
State Street
4
State Street
Massachusetts
$10.6M
5
B
5
Braidwell
Connecticut
$9.49M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
ABG
2
Ally Bridge Group
New York
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Walleye Capital
4
Walleye Capital
New York
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$4.51M
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
101
Tower Research Capital (TRC)
New York
– – -3,897 Closed
Macquarie Group
102
Macquarie Group
Australia
– – -1,824 Closed
EC
103
EntryPoint Capital
New York
– – -363 Closed
FIM
104
Fernwood Investment Management
Massachusetts
– – -102 Closed
CFGS
105
Concourse Financial Group Securities
Alabama
– – – –
1 2 3 4
5